Langerhans Cell Histiocytosis in the central nervous system, cranial and spinal bones: imaging features

Lara Hemerly De Mori1, Gabriela Amaral Ribas1, Luciane Dos Santos Oliveira1

  • 1Department of Diagnostic Imaging, Rio de Janeiro State University, Rio de Janeiro, Brazil.

PubMed

Insights

Langerhans Cell Histiocytosis (LCH) is a rare disorder involving pathological cell growth. This review details CNS, cranial, and spinal bone involvement, focusing on imaging, clinical, and pathological findings.

Area of Science:

  • Oncology
  • Neurology
  • Radiology

Background:

  • Langerhans Cell Histiocytosis (LCH) is a rare neoplastic disorder of pathological dendritic cell proliferation.
  • It is often linked to MAPK pathway activation and BRAF V600E mutations.
  • LCH can affect various organs, including bones, skin, and the central nervous system (CNS).

Purpose of the Study:

  • To review the imaging, clinical, and pathological features of CNS, cranial, and spinal bone involvement in LCH.
  • To discuss the differential diagnosis of LCH in these areas.
  • To highlight the role of imaging in diagnosis and management.

Main Methods:

  • Literature search of PubMed from 1989 to 2024.
  • Inclusion of original research, reviews, and case reports.
  • Exclusion of editorials and letters to the editor.

Main Results:

  • Imaging, including CT and MRI, is crucial for diagnosing LCH bone and CNS involvement.
  • LCH can present as tumoral or neurodegenerative forms with varied symptoms.
  • Accurate diagnosis requires integrating clinical, radiological, and histopathological data.

Conclusions:

  • Comprehensive evaluation is necessary for LCH diagnosis and management.
  • Understanding imaging findings aids in differentiating LCH from other conditions.
  • Further research may refine diagnostic and therapeutic strategies for LCH.
Abstract